Hydrochloric Acid → HCID 178491208, compound
Reaction equation
C(OC([N:8]1[C:16]2[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=2)[C:10]([CH2:17][CH:18]2[C:24](=[O:25])[N:23]([CH2:26][C:27]([N:29]([CH:38]([CH3:40])[CH3:39])[C:30]3[CH:35]=[CH:34][CH:33]=[C:32]([O:36][CH3:37])[CH:31]=3)=[O:28])[C:22]3[CH:41]=[CH:42][CH:43]=[CH:44][C:21]=3[N:20]([C:45]3[CH:50]=[CH:49][CH:48]=[CH:47][CH:46]=3)[C:19]2=[O:51])=[N:9]1)=O)(C)(C)C.Cl.C(OCC)C>O1CCOCC1>[NH:8]1[C:16]2[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=2)[C:10]([CH2:17][CH:18]2[C:24](=[O:25])[N:23]([CH2:26][C:27]([N:29]([CH:38]([CH3:40])[CH3:39])[C:30]3[CH:35]=[CH:34][CH:33]=[C:32]([O:36][CH3:37])[CH:31]=3)=[O:28])[C:22]3[CH:41]=[CH:42][CH:43]=[CH:44][C:21]=3[N:20]([C:45]3[CH:46]=[CH:47][CH:48]=[CH:49][CH:50]=3)[C:19]2=[O:51])=[N:9]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 2-[3-(1-tert-butoxycarbonyl-1H-indazol-3-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]diazepin-1-yl]-N-isopropyl-N-(3-methoxy-phenyl) acetamide, prepared as in Intermediate 74, (250 mg, 0.363 mmol) and 4N HCl in dioxane (2 mL) is stirred at RT for 2 h. Diethyl ether (40 mL) is added and the resultant mixture stirred vigorously for 20 min. The solids were allowed to settle and the solvent is decanted. This procedure is repeated three times and the final solid dried by concentration in vacuo to afford the title compound (197 mg) as a white powdery solid: 1H NMR (300 MHz, CDCl3) δ8.05 (d, 1H, J=8.6), 7.76 (d, 1H, J=8.5), 7.67 (t, 1H, J=8.8), 7.5-7.2 (m, 12H), 7.16 (t, 1H, J=6.3), 6.98 (t, 2H, J=7.3), 5.05 (m, 1H, J=6.9), 4.36 (s, br, 2H), 3.94 (t, 1H, J=7.0), 3.82 (s, br, 2H), 3.74 (s, 3H), 1.16 (m, 6H); Low resolution MS (FAB) m/e 588 (M+).
Workup
- customthe solvent is decanted
- customthe final solid dried by concentration in vacuo
Sources & evidence
- ORD record
- ord-430a8573248641e8af665044e3fe9a8f
- Source dataset
- uspto-grants-1999_01
- Patent number
- US05859007
Reaction notes
Loading…